XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Series A Special Voting
Preferred Stock
Common Stock
Exchangeable Shares
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 164,879 $ (25) $ (149,597) $ 15,257
Balance (in Shares) at Dec. 31, 2022 357 228        
Exchange of exchangeable shares (in Shares)   8 (8)        
Stock-based compensation 1,307 1,307
Unrealized gain on available-for-sale securities 14 14
Net loss (3,148) (3,148)
Balance at Mar. 31, 2023 166,186 (11) (152,745) 13,430
Balance (in Shares) at Mar. 31, 2023 365 220        
Balance at Dec. 31, 2023 $ 1 170,474 (166,392) 4,083
Balance (in Shares) at Dec. 31, 2023 673 95        
Shares issued for reverse stock split (in Shares)   52          
Sale of common stock and warrants 3,431 3,431
Sale of common stock and warrants (in Shares)   563        
Issuance of common stock upon exercise of warrants $ 1 1
Issuance of common stock upon exercise of warrants (in Shares)   1,001        
Stock-based compensation 1,222 1,222
Net loss (2,031) (2,031)
Balance at Mar. 31, 2024 $ 2 $ 175,127 $ (168,423) $ 6,706
Balance (in Shares) at Mar. 31, 2024 2,289 95